ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Autologous Biologics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-6L13631
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medical Autologous Biologics Market Research Report 2023
BUY CHAPTERS

Global Medical Autologous Biologics Market Research Report 2025

Code: QYRE-Auto-6L13631
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vericel Corporation
BioTime
PHARMICELL
Brainstorm Cell Therapeutics
Opexa Therapeutics
Sartorius
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics

Medical Autologous Biologics Market

The global market for Medical Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Medical autologous biologics are therapeutic products derived from a patient"s own cells, tissues, or blood components. The term "autologous" refers to the fact that the source of the biologic material is the individual receiving the treatment. These biologics are personalized medicines, custom-made for each patient, which helps reduce the risk of immune rejection and other complications commonly associated with allogeneic (donor-derived) therapies.
The global market for medical autologous biologics has been experiencing significant growth due to the increasing demand for personalized and regenerative therapies. Autologous biologics offer the advantage of being derived from a patient"s own cells, reducing the risk of immune rejection and adverse reactions. They have found applications in various medical fields, including oncology, orthopedics, cardiovascular diseases, and wound healing. North America, with its well-established healthcare infrastructure and research capabilities, has been a major player in the medical autologous biologics market. European countries have shown increasing interest in regenerative medicine and personalized therapies, driving the adoption of medical autologous biologics. The Asia-Pacific region has seen a surge in research activities and clinical trials focused on autologous biologics, with countries like Japan, China, and South Korea being at the forefront.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Autologous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Autologous Biologics.
The Medical Autologous Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Autologous Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Autologous Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medical Autologous Biologics Market Report

Report Metric Details
Report Name Medical Autologous Biologics Market
Segment by Type
Segment by Application
  • Hospitals
  • Research Center
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Vericel Corporation, BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Sartorius, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medical Autologous Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medical Autologous Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Medical Autologous Biologics Market report?

Ans: The main players in the Medical Autologous Biologics Market are Vericel Corporation, BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Sartorius, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics

What are the Application segmentation covered in the Medical Autologous Biologics Market report?

Ans: The Applications covered in the Medical Autologous Biologics Market report are Hospitals, Research Center, Others

What are the Type segmentation covered in the Medical Autologous Biologics Market report?

Ans: The Types covered in the Medical Autologous Biologics Market report are Adipose Tissue, Plasma, Others

Recommended Reports

Autologous & Cell Therapy

Biologics & Biosimilars

Oncology & Personalized

1 Medical Autologous Biologics Market Overview
1.1 Product Definition
1.2 Medical Autologous Biologics by Type
1.2.1 Global Medical Autologous Biologics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Adipose Tissue
1.2.3 Plasma
1.2.4 Others
1.3 Medical Autologous Biologics by Application
1.3.1 Global Medical Autologous Biologics Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Research Center
1.3.4 Others
1.4 Global Medical Autologous Biologics Market Size Estimates and Forecasts
1.4.1 Global Medical Autologous Biologics Revenue 2020-2031
1.4.2 Global Medical Autologous Biologics Sales 2020-2031
1.4.3 Global Medical Autologous Biologics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medical Autologous Biologics Market Competition by Manufacturers
2.1 Global Medical Autologous Biologics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medical Autologous Biologics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medical Autologous Biologics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medical Autologous Biologics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Autologous Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Autologous Biologics, Product Type & Application
2.7 Global Key Manufacturers of Medical Autologous Biologics, Date of Enter into This Industry
2.8 Global Medical Autologous Biologics Market Competitive Situation and Trends
2.8.1 Global Medical Autologous Biologics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medical Autologous Biologics Players Market Share by Revenue
2.8.3 Global Medical Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Autologous Biologics Market Scenario by Region
3.1 Global Medical Autologous Biologics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medical Autologous Biologics Sales by Region: 2020-2031
3.2.1 Global Medical Autologous Biologics Sales by Region: 2020-2025
3.2.2 Global Medical Autologous Biologics Sales by Region: 2026-2031
3.3 Global Medical Autologous Biologics Revenue by Region: 2020-2031
3.3.1 Global Medical Autologous Biologics Revenue by Region: 2020-2025
3.3.2 Global Medical Autologous Biologics Revenue by Region: 2026-2031
3.4 North America Medical Autologous Biologics Market Facts & Figures by Country
3.4.1 North America Medical Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medical Autologous Biologics Sales by Country (2020-2031)
3.4.3 North America Medical Autologous Biologics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Autologous Biologics Market Facts & Figures by Country
3.5.1 Europe Medical Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medical Autologous Biologics Sales by Country (2020-2031)
3.5.3 Europe Medical Autologous Biologics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Autologous Biologics Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Autologous Biologics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medical Autologous Biologics Sales by Region (2020-2031)
3.6.3 Asia Pacific Medical Autologous Biologics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Autologous Biologics Market Facts & Figures by Country
3.7.1 Latin America Medical Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medical Autologous Biologics Sales by Country (2020-2031)
3.7.3 Latin America Medical Autologous Biologics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Autologous Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medical Autologous Biologics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medical Autologous Biologics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Autologous Biologics Sales by Type (2020-2031)
4.1.1 Global Medical Autologous Biologics Sales by Type (2020-2025)
4.1.2 Global Medical Autologous Biologics Sales by Type (2026-2031)
4.1.3 Global Medical Autologous Biologics Sales Market Share by Type (2020-2031)
4.2 Global Medical Autologous Biologics Revenue by Type (2020-2031)
4.2.1 Global Medical Autologous Biologics Revenue by Type (2020-2025)
4.2.2 Global Medical Autologous Biologics Revenue by Type (2026-2031)
4.2.3 Global Medical Autologous Biologics Revenue Market Share by Type (2020-2031)
4.3 Global Medical Autologous Biologics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medical Autologous Biologics Sales by Application (2020-2031)
5.1.1 Global Medical Autologous Biologics Sales by Application (2020-2025)
5.1.2 Global Medical Autologous Biologics Sales by Application (2026-2031)
5.1.3 Global Medical Autologous Biologics Sales Market Share by Application (2020-2031)
5.2 Global Medical Autologous Biologics Revenue by Application (2020-2031)
5.2.1 Global Medical Autologous Biologics Revenue by Application (2020-2025)
5.2.2 Global Medical Autologous Biologics Revenue by Application (2026-2031)
5.2.3 Global Medical Autologous Biologics Revenue Market Share by Application (2020-2031)
5.3 Global Medical Autologous Biologics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Vericel Corporation
6.1.1 Vericel Corporation Company Information
6.1.2 Vericel Corporation Description and Business Overview
6.1.3 Vericel Corporation Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Vericel Corporation Medical Autologous Biologics Product Portfolio
6.1.5 Vericel Corporation Recent Developments/Updates
6.2 BioTime
6.2.1 BioTime Company Information
6.2.2 BioTime Description and Business Overview
6.2.3 BioTime Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioTime Medical Autologous Biologics Product Portfolio
6.2.5 BioTime Recent Developments/Updates
6.3 Pharmicell
6.3.1 Pharmicell Company Information
6.3.2 Pharmicell Description and Business Overview
6.3.3 Pharmicell Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmicell Medical Autologous Biologics Product Portfolio
6.3.5 Pharmicell Recent Developments/Updates
6.4 BrainStorm Cell Therapeutics
6.4.1 BrainStorm Cell Therapeutics Company Information
6.4.2 BrainStorm Cell Therapeutics Description and Business Overview
6.4.3 BrainStorm Cell Therapeutics Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BrainStorm Cell Therapeutics Medical Autologous Biologics Product Portfolio
6.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
6.5 Opexa Therapeutics
6.5.1 Opexa Therapeutics Company Information
6.5.2 Opexa Therapeutics Description and Business Overview
6.5.3 Opexa Therapeutics Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Opexa Therapeutics Medical Autologous Biologics Product Portfolio
6.5.5 Opexa Therapeutics Recent Developments/Updates
6.6 Sartorius
6.6.1 Sartorius Company Information
6.6.2 Sartorius Description and Business Overview
6.6.3 Sartorius Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sartorius Medical Autologous Biologics Product Portfolio
6.6.5 Sartorius Recent Developments/Updates
6.7 Neostem
6.7.1 Neostem Company Information
6.7.2 Neostem Description and Business Overview
6.7.3 Neostem Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Neostem Medical Autologous Biologics Product Portfolio
6.7.5 Neostem Recent Developments/Updates
6.8 Dendreon Corporation
6.8.1 Dendreon Corporation Company Information
6.8.2 Dendreon Corporation Description and Business Overview
6.8.3 Dendreon Corporation Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dendreon Corporation Medical Autologous Biologics Product Portfolio
6.8.5 Dendreon Corporation Recent Developments/Updates
6.9 Regenexx
6.9.1 Regenexx Company Information
6.9.2 Regenexx Description and Business Overview
6.9.3 Regenexx Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Regenexx Medical Autologous Biologics Product Portfolio
6.9.5 Regenexx Recent Developments/Updates
6.10 Cytori Therapeutics
6.10.1 Cytori Therapeutics Company Information
6.10.2 Cytori Therapeutics Description and Business Overview
6.10.3 Cytori Therapeutics Medical Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cytori Therapeutics Medical Autologous Biologics Product Portfolio
6.10.5 Cytori Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Autologous Biologics Industry Chain Analysis
7.2 Medical Autologous Biologics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Autologous Biologics Production Mode & Process Analysis
7.4 Medical Autologous Biologics Sales and Marketing
7.4.1 Medical Autologous Biologics Sales Channels
7.4.2 Medical Autologous Biologics Distributors
7.5 Medical Autologous Biologics Customer Analysis
8 Medical Autologous Biologics Market Dynamics
8.1 Medical Autologous Biologics Industry Trends
8.2 Medical Autologous Biologics Market Drivers
8.3 Medical Autologous Biologics Market Challenges
8.4 Medical Autologous Biologics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Vericel Corporation
BioTime
PHARMICELL
Brainstorm Cell Therapeutics
Opexa Therapeutics
Sartorius
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
List of Tables
 Table 1. Global Medical Autologous Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medical Autologous Biologics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medical Autologous Biologics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medical Autologous Biologics Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Medical Autologous Biologics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medical Autologous Biologics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medical Autologous Biologics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medical Autologous Biologics Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medical Autologous Biologics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medical Autologous Biologics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medical Autologous Biologics, Product Type & Application
 Table 12. Global Key Manufacturers of Medical Autologous Biologics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Autologous Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Autologous Biologics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Autologous Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medical Autologous Biologics Sales by Region (2020-2025) & (Kg)
 Table 18. Global Medical Autologous Biologics Sales Market Share by Region (2020-2025)
 Table 19. Global Medical Autologous Biologics Sales by Region (2026-2031) & (Kg)
 Table 20. Global Medical Autologous Biologics Sales Market Share by Region (2026-2031)
 Table 21. Global Medical Autologous Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medical Autologous Biologics Revenue Market Share by Region (2020-2025)
 Table 23. Global Medical Autologous Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medical Autologous Biologics Revenue Market Share by Region (2026-2031)
 Table 25. North America Medical Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medical Autologous Biologics Sales by Country (2020-2025) & (Kg)
 Table 27. North America Medical Autologous Biologics Sales by Country (2026-2031) & (Kg)
 Table 28. North America Medical Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medical Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medical Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medical Autologous Biologics Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Medical Autologous Biologics Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Medical Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medical Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medical Autologous Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medical Autologous Biologics Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Medical Autologous Biologics Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Medical Autologous Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medical Autologous Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medical Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medical Autologous Biologics Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Medical Autologous Biologics Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Medical Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medical Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medical Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medical Autologous Biologics Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Medical Autologous Biologics Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Medical Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medical Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medical Autologous Biologics Sales (Kg) by Type (2020-2025)
 Table 51. Global Medical Autologous Biologics Sales (Kg) by Type (2026-2031)
 Table 52. Global Medical Autologous Biologics Sales Market Share by Type (2020-2025)
 Table 53. Global Medical Autologous Biologics Sales Market Share by Type (2026-2031)
 Table 54. Global Medical Autologous Biologics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medical Autologous Biologics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medical Autologous Biologics Revenue Market Share by Type (2020-2025)
 Table 57. Global Medical Autologous Biologics Revenue Market Share by Type (2026-2031)
 Table 58. Global Medical Autologous Biologics Price (US$/g) by Type (2020-2025)
 Table 59. Global Medical Autologous Biologics Price (US$/g) by Type (2026-2031)
 Table 60. Global Medical Autologous Biologics Sales (Kg) by Application (2020-2025)
 Table 61. Global Medical Autologous Biologics Sales (Kg) by Application (2026-2031)
 Table 62. Global Medical Autologous Biologics Sales Market Share by Application (2020-2025)
 Table 63. Global Medical Autologous Biologics Sales Market Share by Application (2026-2031)
 Table 64. Global Medical Autologous Biologics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medical Autologous Biologics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medical Autologous Biologics Revenue Market Share by Application (2020-2025)
 Table 67. Global Medical Autologous Biologics Revenue Market Share by Application (2026-2031)
 Table 68. Global Medical Autologous Biologics Price (US$/g) by Application (2020-2025)
 Table 69. Global Medical Autologous Biologics Price (US$/g) by Application (2026-2031)
 Table 70. Vericel Corporation Company Information
 Table 71. Vericel Corporation Description and Business Overview
 Table 72. Vericel Corporation Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Vericel Corporation Medical Autologous Biologics Product
 Table 74. Vericel Corporation Recent Developments/Updates
 Table 75. BioTime Company Information
 Table 76. BioTime Description and Business Overview
 Table 77. BioTime Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. BioTime Medical Autologous Biologics Product
 Table 79. BioTime Recent Developments/Updates
 Table 80. Pharmicell Company Information
 Table 81. Pharmicell Description and Business Overview
 Table 82. Pharmicell Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Pharmicell Medical Autologous Biologics Product
 Table 84. Pharmicell Recent Developments/Updates
 Table 85. BrainStorm Cell Therapeutics Company Information
 Table 86. BrainStorm Cell Therapeutics Description and Business Overview
 Table 87. BrainStorm Cell Therapeutics Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. BrainStorm Cell Therapeutics Medical Autologous Biologics Product
 Table 89. BrainStorm Cell Therapeutics Recent Developments/Updates
 Table 90. Opexa Therapeutics Company Information
 Table 91. Opexa Therapeutics Description and Business Overview
 Table 92. Opexa Therapeutics Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Opexa Therapeutics Medical Autologous Biologics Product
 Table 94. Opexa Therapeutics Recent Developments/Updates
 Table 95. Sartorius Company Information
 Table 96. Sartorius Description and Business Overview
 Table 97. Sartorius Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. Sartorius Medical Autologous Biologics Product
 Table 99. Sartorius Recent Developments/Updates
 Table 100. Neostem Company Information
 Table 101. Neostem Description and Business Overview
 Table 102. Neostem Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. Neostem Medical Autologous Biologics Product
 Table 104. Neostem Recent Developments/Updates
 Table 105. Dendreon Corporation Company Information
 Table 106. Dendreon Corporation Description and Business Overview
 Table 107. Dendreon Corporation Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Dendreon Corporation Medical Autologous Biologics Product
 Table 109. Dendreon Corporation Recent Developments/Updates
 Table 110. Regenexx Company Information
 Table 111. Regenexx Description and Business Overview
 Table 112. Regenexx Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Regenexx Medical Autologous Biologics Product
 Table 114. Regenexx Recent Developments/Updates
 Table 115. Cytori Therapeutics Company Information
 Table 116. Cytori Therapeutics Description and Business Overview
 Table 117. Cytori Therapeutics Medical Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. Cytori Therapeutics Medical Autologous Biologics Product
 Table 119. Cytori Therapeutics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Medical Autologous Biologics Distributors List
 Table 123. Medical Autologous Biologics Customers List
 Table 124. Medical Autologous Biologics Market Trends
 Table 125. Medical Autologous Biologics Market Drivers
 Table 126. Medical Autologous Biologics Market Challenges
 Table 127. Medical Autologous Biologics Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Autologous Biologics
 Figure 2. Global Medical Autologous Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medical Autologous Biologics Market Share by Type: 2024 & 2031
 Figure 4. Adipose Tissue Product Picture
 Figure 5. Plasma Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Medical Autologous Biologics Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Medical Autologous Biologics Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Research Center
 Figure 11. Others
 Figure 12. Global Medical Autologous Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Medical Autologous Biologics Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Medical Autologous Biologics Sales (2020-2031) & (Kg)
 Figure 15. Global Medical Autologous Biologics Average Price (US$/g) & (2020-2031)
 Figure 16. Medical Autologous Biologics Report Years Considered
 Figure 17. Medical Autologous Biologics Sales Share by Manufacturers in 2024
 Figure 18. Global Medical Autologous Biologics Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Medical Autologous Biologics Players: Market Share by Revenue in Medical Autologous Biologics in 2024
 Figure 20. Medical Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Medical Autologous Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Medical Autologous Biologics Sales Market Share by Country (2020-2031)
 Figure 23. North America Medical Autologous Biologics Revenue Market Share by Country (2020-2031)
 Figure 24. United States Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Medical Autologous Biologics Sales Market Share by Country (2020-2031)
 Figure 27. Europe Medical Autologous Biologics Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Medical Autologous Biologics Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Medical Autologous Biologics Revenue Market Share by Region (2020-2031)
 Figure 35. China Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Medical Autologous Biologics Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Medical Autologous Biologics Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Medical Autologous Biologics Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Medical Autologous Biologics Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Medical Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Medical Autologous Biologics by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Medical Autologous Biologics by Type (2020-2031)
 Figure 54. Global Medical Autologous Biologics Price (US$/g) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Medical Autologous Biologics by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Medical Autologous Biologics by Application (2020-2031)
 Figure 57. Global Medical Autologous Biologics Price (US$/g) by Application (2020-2031)
 Figure 58. Medical Autologous Biologics Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Autologous Cell Therapy Products Market Research Report 2024
Global Autologous Biologics Market Research Report 2025
Global Biologic Medical Product Market Research Report 2025
Global Autologous Cell Therapy Market Insights Forecast to 2030
Global Medical Wound Care Biologics Market Research Report 2025
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Global Cancer Biopharmaceuticals Market Insights Forecast to 2030
Global Biologics and Biosimilars Market Research Report 2025
Autologous Transfusion Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autologous Stem Cell Based Therapies Market Research Report 2024
Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autogenous Vaccines Market Insights Forecast to 2030
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Non oncology Biopharmaceuticals Market Insights Forecast to 2030
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Biologics Market Research Report 2024
Global Biologics Outsourcing Services Market Research Report 2024
Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions